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Abstract
Guidelines help to prevent the transmission of Mycobacterium tuberculosis in healthcare settings, but may also result in the unnecessary
isolation of many patients. We performed a prospective study to assess the prevalence and identify clinical predictors of culture-proven
tuberculosis among inpatients isolated for suspected pulmonary tuberculosis (PTB) at our hospital. We also wished to validate a pre-
existing clinical decision rule to improve our isolation policy. From August 2005 to January 2007, 134 patients isolated on admission to
the ward for suspicion of PTB were prospectively enrolled. The admitting team made the decision to isolate patients on the basis of
clinical and radiological ﬁndings, without the use of the clinical decision rule, and graded the overall suspicion of PTB. Twenty-six of the
134 isolated patients had PTB (prevalence: 19.4%), as well as one patient not isolated at admission. Univariate analysis revealed that
PTB was signiﬁcantly associated with young age, lack of human immunodeﬁciency virus (HIV) infection, weight loss, night sweats, fever,
upper lobe disease and, especially, cavitary lesions on chest X-ray (adjusted OR 25.4, p <0.0001). Low suspicion of PTB by the admitting
team and low clinical decision rule score had negative predictive values of 98.5% and 95.8% for PTB, respectively. Use of the clinical
decision rule in addition to the team assessment would have led to the isolation of the patient with PTB not isolated on admission, and
avoided 16 (14.8%) unnecessary isolations. In conclusion, the prevalence of PTB among isolated inpatients was high, and the use of a
clinical decision rule in addition to clinical impression might improve isolation decisions.
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Introduction
Transmission of tuberculosis (TB) in healthcare settings has
become a growing concern in the era of human immunodeﬁ-
ciency virus (HIV) infection and multidrug-resistant TB [1,2].
Guidelines based on the early detection and isolation of
patients with suspected pulmonary TB (PTB), recommending
the use of single-patient rooms with environmental and
respiratory-protection controls until three sputum smears
for acid-fast bacilli (AFB) are negative, have led to a decrease
in the risk of acquiring TB for both healthcare workers and
patients [3–6]. However, these measures may also result in
the unnecessary isolation of many patients at low risk for
PTB, with signiﬁcant organizational constraints for the ward,
psychological pressure on the isolated patients and their visi-
tors, and an overall increase in hospital costs.
A number of clinical decision rules (CDRs) based on clini-
cal and radiological ﬁndings on admission to the hospital have
been developed to help identify patients who are at high or
low risk of PTB, and thus improve decisions about respira-
tory isolation of these patients [7–12].
We performed a prospective study to assess the preva-
lence and identify predictive clinical factors of culture-proven
TB among inpatients isolated for suspected PTB in our ward,
and assessed whether the CDR developed by Wisnivesky
would improve the selection of inpatients for respiratory
isolation [9,10].
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Materials and Methods
Patient population
The study was conducted in the Department of Infectious
Diseases of the Saint-Louis Hospital, a 563-bed tertiary-care
institution in Paris. The infectious disease ward is a 30-bed
unit. The incidence of TB in Paris is 19.7/100 000, more than
twice the national rate, with 1.3% of cases being multidrug-
resistant TB. The institutional review board of the hospital
approved the study.
From 1 August 2005 to 31 January 2007, all patients admit-
ted to the ward and isolated because of suspected PTB, as rec-
ommended by French guidelines, were prospectively enrolled
in the study. The decision to isolate patients was not based on
Wisnivesky’s CDR, but made by the admitting team, who
graded the suspicion of PTB as high, low or intermediate. The
admitting team comprised infectious diseases specialists with
good clinical experience in TB. Patients were not enrolled in
the study if they were receiving anti-TB medication at the time
of admission, or had a known positive AFB sputum smear.
The respiratory isolation policy in our ward is to isolate
on admission patients with suspected PTB in single-patient
rooms, with strict respiratory protection of healthcare work-
ers and visitors, who are instructed to use FFP2 masks before
entering the room, and with a strong recommendation for
the isolated patient to put on a surgical mask when someone
enters the room. The ward does not have negative-pressure
rooms, air ﬁltration or controlled ventilation, but windows
remain open for at least 4 h a day to dilute contaminated air.
Data collection
Data were prospectively collected within 24 h of patients’
admission, from patients’ charts, before the results of the
AFB sputum smears were available. Demographic data, the
presence of TB risk factors, clinical symptoms and ﬁndings
from physical examination, laboratory tests and chest radiog-
raphy were recorded. Demographic data included age, sex
and country of origin. Risk factors for TB included a previous
history of or exposure to TB, a history of positive tuberculin
skin test ﬁndings, homelessness, previous stays in social shel-
ters or prisons, and HIV infection. Clinical symptoms
included signiﬁcant weight loss (at least 10% of body weight),
chills, night sweats of ‡3 weeks’ duration, persistent fever
for ‡3 weeks, a history of shortness of breath, cough, puru-
lent sputum, haemoptysis, chest pain and rhinorrhea. Data
from the physical examination included body temperature on
admission, oxygen saturation level, the presence of crackles
and/or rhonchi/wheezing during chest examination, and the
presence of peripheral lymphadenopathy. Laboratory data
included neutrophil and platelet counts, and haemoglobin,
C-reactive protein, aspartate aminotransferase and alkaline
phosphatase levels.
Chest radiographs were also reviewed for the presence of
upper lobe involvement, reticulonodular inﬁltrate, consolida-
tion, cavitations, pleural effusion and the presence of medias-
tinal lymphadenopathy.
Finally, a score was calculated for each patient according
to the CDR deﬁned and validated by Wisnivesky and summa-
rized in Table 1 [9,10]. Patients with a score of )6–0 should
not be isolated, and patients with a score of at least 1 should
be isolated. This score was not used for the clinical manage-
ment of the enrolled patients.
Sputum sample assessment
A patient was considered to have active PTB if at least one
sputum culture was positive for the Mycobacterium tuberculo-
sis complex. Sputum samples were concentrated and stained
with Auramine O ﬂuorescent stain for smear examination
and AFB quantiﬁcation. For cultures, samples were inocu-
lated in Bactec 960 MGIT and Coletsos Medium. Cultures
were maintained for at least 42 days to detect the presence
of growing organisms.
Statistical analysis
Data are described as mean (standard deviation) or count
(%). Baseline characteristics of isolated patients with or with-
out PTB were compared with the Fisher exact test for pro-
portions and the Welsch modiﬁcation of the t-test or
Wilcoxon rank sum test for continuous variables. The
strength of association between baseline characteristics and
PTB was expressed in terms of ORs with 95% CIs.
The classiﬁcation performances of the admitting team and
of the Wisnivesky CDR for the diagnosis of PTB were assessed
TABLE 1. Wisnivesky’s clinical prediction rule and point
scoring systema
Variable Points assigned
Tuberculosis risk factors or chronic symptomsb 4
Self-reported positive tuberculin skin test 5
Shortness of breath )3
Temperature (C)
<38.5 0
38.5–39 3
>39.0 6
Crackles on physical examination )3
Upper lobe disease on chest radiographs 6
aWisnivesky et al. [9]. Patients with a score of )6–0 should not be isolated, and
patients with a score of at least 1 should be isolated.
bAny of the following: exposure to an individual with tuberculosis, institutionali-
zation (prison, shleter, nursing home) in the past 3 years, homelessness, weight
loss ‡10% of body weight, night sweats for ‡3 weeks, symptoms of malaise or
weakness for ‡3 months, and persistent fever.
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by calculating sensitivity, speciﬁcity, positive predictive value
(PPV) and negative predictive value (NPV), with 95% CIs. The
potential reduction in the number of unnecessary isolated
patients with the use of the CDR was calculated.
All tests were two-sided, and p-values <0.05 were
regarded as indicating statistical signiﬁcance. Analyses were
performed using the R 2.6.2 statistical package (R Foundation
for Statistical Computing, Vienna, Austria).
Results
During the study period, 1207 patients were admitted to
our ward, 716 of whom were HIV-infected (prevalence:
59%), and 134 patients (11.1%) were placed in respiratory
isolation on admission for suspected PTB. Baseline character-
istics of these isolated patients are shown in Table 2. Most
patients were male (70%), with a mean age of 43 years; 47%
originated from sub-Saharan Africa; 22% of them had a his-
tory of TB; and 45% were HIV-infected. Cough was reported
by 62% of patients, and was the most frequent clinical symp-
tom. Also, 46% of patients had a pulmonary inﬁltrate on
chest X-ray, involving upper lobes in 43%.
Twenty-six of the 134 isolated patients had culture-proven
PTB, with M. tuberculosis identiﬁed in 24 cases, and Myco-
bacterium africanum in two. Fourteen (53.8%) of these
patients had a positive AFB sputum smear. The prevalence of
PTB among isolated inpatients in our study was therefore
19.4% (95% CI 13.6–26.7), and was 2.2% among admitted
patients.
Among the 108 isolated patients who did not have PTB,
nine presented with extrapulmonary TB. Three HIV-infected
TABLE 2. Comparison of baseline characteristics between patients with and without culture-proven pulmonary tuberculosis
(PTB)
Variable
Total
n = 134
Patients
with PTB
n = 26
Patients
without PTB
n = 108 p-Value OR (95% CI)a
Demographics
Age (years), mean (SD) 43 (14) 37 (12) 45 (14) 0.0075 0.62/10 years (0.42–0.91)
Male sex, N (%) 94 (70) 19 (73) 75 (69) 0.81 1.19 (0.46–3.11)
Country of origin
Europe 35 (26) 6 (23) 29 (27) 0.89 1 (reference)
Sub-Saharan Africa 63 (47) 12 (46) 51 (47) 1.14 (0.39–3.35)
Other 36 (27) 8 (31) 28 (26) 1.38 (0.42–4.49)
TB risk factors, N (%) 49 (39) 9 (39) 40 (38) >0.99 1.03 (0.41–2.60)
Previous history of TB, N (%) 30 (22) 3 (12) 27 (25) 0.19 0.39 (0.11–1.41)
TST >5 mm, N (%) 6 (4) 1 (4) 5 (5) >0.99 0.82 (0.09–7.37)
HIV infection, N (%) 60 (45) 7 (27) 53 (49) 0.049 0.38 (0.15–0.98)
Clinical symptoms
Weight loss ‡10%, N (%) 47 (35) 14 (54) 33 (31) 0.038 2.65 (1.11–6.35)
Chills, N (%) 27 (20) 4 (16) 23 (21) 0.78 0.70 (0.22–2.23)
Night sweats >3 weeks, N (%) 33 (25) 11 (42) 22 (21) 0.040 2.83 (1.14–7.03)
Fever >3 weeks, N (%) 35 (27) 11 (42) 24 (23) 0.050 2.51 (1.02–6.17)
Shortness of breath, N (%) 41 (31) 5 (19) 36 (34) 0.16 0.46 (0.16–1.33)
Cough, N (%) 82 (62) 16 (62) 66 (62) >0.99 0.99 (0.41–2.40)
Purulent sputum, N (%) 30 (22) 7 (27) 23 (21) 0.60 1.36 (0.51–3.63)
Haemoptysis, N (%) 11 (8) 3 (12) 8 (7) 0.45 1.61 (0.40–6.56)
Chest pain, N (%) 25 (19) 5 (19) 20 (19) >0.99 1.04 (0.35–3.08)
Rhinorrhea, N (%) 3 (2) 0 (0) 3 (3) >0.99 1.05 (0–9.95)b
Body temperature (C), mean (SD) 37.6 (1.1) 38 (1.0) 37.5 (1.0) 0.024
N (%) ‡38C 49 (37) 16 (64) 33 (31) 0.0026 4.04 (1.62–10.1)
Percentage oxygen saturation, mean (SD) 96.9 (2.4) 97 (1.5) 96.9 (2.6) 0.81 1.01 (0.42–2.46)
Crackles, N (%) 29 (22) 5 (19) 24 (22) >0.99 0.82 (0.28–2.41)
Rhonchi/wheezing, N (%) 23 (17) 5 (19) 18 (17) 0.77 1.19 (0.40–3.57)
Peripheral lymphadenopathy, N (%) 44 (33) 7 (27) 37 (34) 0.64 0.71 (0.27–1.83)
Laboratory values
Neutrophil count, ·109/L 4.4 (3–8) 6.0 (3.4–8.2) 3.9 (2.8–8.0) 0.15 2.66 (0.98–8.97)
Haemoglobin (g/dL), mean (SD) 12.2 (2.0) 12.1 (1.8) 12.2 (2.1) 0.75 1.17 (0.49–2.75)
Platelet count, ·109/L 276 (212–359) 328 (246–380) 265 (204–341) 0.14 2.19 (0.90–5.35)
C-reactive protein (mg/L) 50 (14–104) 57 (20–112) 43 (10–104) 0.30 1.43 (0.58–3.49)
ASAT (IU/L) 26 (19–38) 28 (20–43) 26 (19–37) 0.59 1.17 (0.49–2.75)
Alkaline phosphatase (IU/L) 79 (60–113) 86 (63–126) 76 (60–111) 0.41 1.72 (0.72–4.14)
Chest radiographs
Upper lobe disease, N (%) 58 (43) 18 (69) 40 (37) 0.0039 3.82 (1.52–9.60)
Pulmonary inﬁltrate, N (%) 62 (46) 15 (58) 47 (44) 0.27 1.77 (0.74–4.21)
Consolidation, N (%) 33 (25) 8 (31) 25 (23) 0.45 1.46 (0.57–3.75)
Cavitation, N (%) 14 (11) 11 (42) 3 (3) <0.0001 25.4 (6.35–101.7)
Pleural effusion, N (%) 17 (13) 5 (19) 12 (11) 0.32 1.88 (0.60–5.93)
Mediastinal lymph nodes, N (%) 11 (8) 2 (8) 9 (8) >0.99 0.91 (0.18–4.48)
ASAT, aspartate aminotransferase; HIV, human immunodeﬁciency virus; SD, standard deviation; TB, tuberculosis; TST, tuberculin skin test.
aFor continuous variables, ORs are given for a cut-off value at the sample median except otherwise stated.
bObtained by exact logistic regression.
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patients had Mycobacterium avium identiﬁed in sputum cul-
tures, one of whom had a positive AFB sputum smear.
In the univariate analysis, patients with PTB in our study
were signiﬁcantly younger, less frequently HIV-infected and
had more frequently experienced weight loss, night sweats
and fever than patients without TB (Table 2). Patients with
TB also had more frequent upper lobe involvement and
more cavitary lesions on chest X-ray. There were no differ-
ences in respiratory symptoms and laboratory parameters
between patients with or without PTB.
The performances of the admitting team and of the Wis-
nivesky CDR for the diagnosis of PTB are reported in
Table 3. A high or intermediate suspicion of PTB by the
admitting team was signiﬁcantly associated with PTB
(p <0.0001), with a sensitivity of 96.2%, a speciﬁcity of
63.8%, a PPV of 39%, and an NPV of 98.5%. Indeed, only one
patient with a low suspicion of PTB and negative AFB spu-
tum smear had PTB. This 36-year-old HIV-negative man from
India was admitted for a weight loss of 3 kg, with haemoptysis,
without fever or night sweats, and with mediastinal lymph-
adenopathies on chest X-ray without visible inﬁltrate. He
had a suspicion of lymphoma and his Wisnivesky score
was 4.
The Wisnivesky score was also signiﬁcantly associated
with the diagnosis of PTB, with a sensitivity of 96.2%, a spec-
iﬁcity of 21.3%, a PPV of 22.7%, and an NPV of 95.8%. Use
of the CDR would have correctly identiﬁed all but one
patient with PTB. This 25-year-old HIV-negative man, origi-
nating from Mali, was admitted for a 2-week history of low-
grade fever, and a thoracic abscess; he had mediastinal
lymphadenopathies and rib osteolysis with a left lower lobe
consolidation on chest X-ray. He had negative AFB sputum
smears, with a Wisnivesky score of 0, and was isolated with
an intermediate suspicion of PTB.
However, during the study period, one patient not iso-
lated on admission was eventually found to have culture-pro-
ven PTB, with a positive AFB sputum smear. This patient had
a Wisnivesky score of 6, and would have been isolated had
the score been used for the decision regarding isolation. This
39-year-old HIV-infected man from the Democratic Republic
of Congo was admitted with a diagnosis of acute bacterial
pneumonia of the left lower lobe, and AFB sputum smears
were ordered only after 5 days of unsuccessful antibiotic
treatment.
Among patients without PTB, 69 had a low suspicion of
PTB at admission, and 16 of these patients also had a Wis-
nivesky score of <1 (Table 3). If the Wisnivesky CDR had
been used in addition to the admitting team impression,
among the 108 patients isolated without PTB, 16 (14.8%)
patients could have avoided isolation.
Discussion
Guidelines for preventing the transmission of M. tuberculosis
in healthcare settings are effective, but delays in recognition
and isolation of patients with active PTB may still occur
[3–6,13]. Strict enforcement of these guidelines may also
result in the unnecessary isolation of many patients at low
risk for PTB, especially in low-endemicity areas [7,9]. There-
fore, regular assessment of these policies is recommended,
including review of new tools to improve isolation decisions.
CDRs are based on standardized clinical and radiological
ﬁndings available at the time of patient admission, and can
help to improve isolation decisions [7–12].
In our prospective assessment of our PTB isolation policy,
134 (11.1%) of the 1207 admitted patients were isolated for
suspicion of PTB. The prevalence of culture-proven PTB
among these patients was 19.4%, much higher than in previ-
ous studies [10]. We failed, however, to isolate one patient
with active PTB until 5 days after admission, although the
CDR would have recommended doing so. This failure to iso-
late 1/27 (3.7%) patients with active PTB has public health
implications, both for other patients and for healthcare
workers [14].
When assessing clinical and radiological predictors of PTB
among isolated patients in our study, we were able to iden-
tify, in the univariate analysis, the presence of cavitations on
chest X-ray as the main factor signiﬁcantly associated with
the presence of PTB. This factor is used in most CDRs for
the isolation of patients with suspected PTB [7–12,15].
However, we were unable to identify predictive factors
associated with the absence of PTB on admission. Although a
low suspicion of PTB by the admitting team had an NPV for
PTB in our study (98.5%), one isolated patient with a low
clinical suspicion of PTB was found to have PTB. The use of
the Wisnivesky CDR would have correctly identiﬁed this
patient as needing isolation. Had the Wisnivesky CDR been
TABLE 3. Concordance of clinical impression of the admit-
ting team and of the Wisnivesky clinical prediction rule in
isolated patients with and without culture-proven pulmo-
nary tuberculosis (PTB)
Clinical suspicion
of PTB
PTB
N = 26
No PTB
N = 108
W < 1 W ‡ 1 W < 1 W ‡ 1
Low 0 1 16 53
Intermediate/high 1 24 7 32
W, Wisnivesky score.
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applied to the 69 patients without PTB who had a low suspi-
cion at admission, 16 patients with CDR scores below 1
would have avoided unnecessary isolations (Table 3).
However, the Wisnivesky CDR alone would not have per-
formed better than the admitting team, as one patient with
TB would have been missed and not isolated. Also, we could
not assess in this study the total number of patients who
would have been isolated had the Wisnivesky CDR been
applied to the whole study population. Indeed, in this study,
the Wisnivesky CDR did not perform as well as in others,
with a somewhat lower speciﬁcity and NPV of 21.3% and
95.8%, respectively [9,10,16]. Decision rules should be used
to help in decision-making, not to replace the clinical assess-
ment.
Our study had several limitations. The experience of the
admitting physicians in this study might explain the good per-
formance of clinical suspicion as compared with the CDR. The
number of patients with culture-conﬁrmed PTB was low, and
we should be careful before generalizing our ﬁndings. Also,
our study focused on patients with culture-proven PTB; only
53.8% of them had positive AFB sputum smears and were
therefore highly contagious. Finally, our results may only apply
to the patient population that we investigated, i.e. inpatients in
a ward with a high prevalence of HIV infection.
In conclusion, we suggest that the use of a CDR in addi-
tion to the clinical judgement of the admitting team might
improve our decisions regarding the need for isolation of
patients admitted with suspected PTB. Such a beneﬁt needs
to be further evaluated in a prospective study to assess the
adequate isolation of all contagious patients while minimizing
the unnecessary isolation of patients without PTB.
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